Understanding brain lesions in multiple sclerosis and related disorders
Official title: Longitudinal Investigation of Cortical Demyelination and Meningeal Inflammation in Multiple Sclerosis and Related Disorders
Run by Icahn School of Medicine at Mount Sinai · NCT05982925 · Data updated 2026-11-12
This study looks at how brain lesions develop in people with multiple sclerosis and similar conditions over time to better understand their effects and progression.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | May 6, 2022 |
| Main results expected | July 31, 2028 |
| Study ends | July 31, 2034 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT05982925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older diagnosed with multiple sclerosis, neuromyelitis optica, or other demyelinating autoimmune diseases.
✕Probably not a fit
Patients who are pregnant or have contraindications to MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the natural history and immunologic mechanisms of central nervous system lesions, particularly in the cerebral cortex, in patients with multiple sclerosis and other demyelinating autoimmune diseases. Participants, including healthy controls, will undergo a series of evaluations including MRI scans, blood tests, and cerebrospinal fluid analysis at baseline and follow-ups over six years. The study will also monitor new lesion formation and compare different MRI techniques. The goal is to gain insights into the clinical implications of these lesions and their progression over time.
Why it matters
Potential benefit: If successful, this study could enhance understanding of multiple sclerosis and related disorders, potentially leading to improved diagnostic and therapeutic strategies.
How similar studies have gone: While this study employs established methodologies, the specific focus on longitudinal cortical demyelination in this context may provide novel insights, as similar studies have shown varying degrees of success in understanding CNS lesions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years old * able to provide consent in English * able to undergo MRI Exclusion Criteria: * contraindication to MRI * pregnancy
Where it's running
-
Mount Sinai Hospital
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Erin S Beck, MD, PhD — Icahn School of Medicine at Mount Sinai
- Study coordinator: Erin S Beck, MD, PhD
- Email: erin.beck@mssm.edu
- Phone: 212-241-2474
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Music-4-MS: A 12-week music-based program to support thinking skills in people with MS
A 12-week music-based program is tested to see if it helps cognitive function and mood in people living with multiple sclerosis.
-
Comparing Rituximab and Ocrelizumab for Treating Relapsing Multiple Sclerosis
This study is testing if rituximab works just as well as ocrelizumab for treating relapsing multiple sclerosis in adults.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.